Gabelli Funds LLC Pfizer Inc Transaction History

Gabelli Funds LLC

$12.3 Billion
Q2 2024

A detailed history of Gabelli Funds LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gabelli Funds LLC holds 742,113 shares of PFE stock, worth $20.4 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

742,113

Previous 710,413 4.46%

Holding current value

$20.4 Million

Previous $19.7 Million 5.33%

% of portfolio

0.17%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $800,742 - $938,320	31,700 Added 4.46%	742,113 $20.8 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $3.45 Million - $3.96 Million	133,200 Added 23.08%	710,413 $19.7 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $593,151 - $770,438	-22,700 Reduced 3.78%	577,213 $16.6 Million
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $89,852 - $105,028	-2,800 Reduced 0.46%	599,913 $19.9 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $23,478 - $27,163	650 Added 0.11%	602,713 $22.1 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $183,163 - $238,452	4,650 Added 0.78%	602,063 $24.6 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $6,262 - $8,175	-150 Reduced 0.03%	597,413 $30.6 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $210,048 - $256,416	-4,800 Reduced 0.8%	597,563 $26.1 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $225,670 - $267,574	4,850 Added 0.81%	602,363 $31.6 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $77,775 - $96,373	-1,700 Reduced 0.28%	597,513 $30.9 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $950,360 - $1.41 Million	-23,000 Reduced 3.7%	599,213 $35.4 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $3.66 Million - $4.7 Million	93,125 Added 17.6%	622,213 $26.8 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $161,594 - $183,060	-4,500 Reduced 0.84%	529,088 $20.7 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $133,960 - $151,080	-4,000 Reduced 0.74%	533,588 $19.3 Million
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $66,940 - $85,120	-2,000 Reduced 0.37%	537,588 $19.8 Million
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $190,500 - $223,500	-6,000 Reduced 1.1%	539,588 $19.8 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $4.49 Million - $5.45 Million	-149,136 Reduced 21.47%	545,588 $17.8 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $216,240 - $308,960	8,000 Added 1.16%	694,724 $22.7 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $460,880 - $523,040	14,000 Added 2.08%	686,724 $26.9 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $487,350 - $631,950	-15,000 Reduced 2.18%	672,724 $24.2 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $887,519 - $996,480	-24,000 Reduced 3.37%	687,724 $29.8 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $1.48 Million - $1.63 Million	-39,500 Reduced 5.26%	711,724 $30.2 Million
Q4 2018 Jan 30, 2019	SELL	$38.47 - $43.86 $7.12 Million - $8.12 Million	-185,200 Reduced 19.78%	751,224 $32.8 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $1.55 Million - $1.88 Million	-45,000 Reduced 4.59%	936,424 $41.3 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $2.45 Million - $2.61 Million	-74,300 Reduced 7.04%	981,424 $35.6 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $111,685 - $129,570	-3,500 Reduced 0.33%	1,055,724 $37.5 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $6.06 Million - $6.43 Million	-182,324 Reduced 14.69%	1,059,224 $38.4 Million
Q3 2017 Nov 01, 2017	BUY	$31.0 - $34.15 $38.5 Million - $42.4 Million	1,241,548	1,241,548 $44.3 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Pfizer Inc Transaction History